Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $206,668 | 70 | 51.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $101,215 | 21 | 25.1% |
| Travel and Lodging | $60,435 | 59 | 15.0% |
| Grant | $25,000 | 1 | 6.2% |
| Food and Beverage | $6,472 | 121 | 1.6% |
| Unspecified | $1,800 | 2 | 0.4% |
| Honoraria | $1,425 | 3 | 0.4% |
| Education | $187.12 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | $204,883 | 130 | $0 (2024) |
| Insmed, Inc. | $118,549 | 90 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $19,666 | 1 | $0 (2017) |
| Advanced Respiratory, Inc | $13,475 | 14 | $0 (2021) |
| Boehringer Ingelheim International GmbH | $9,363 | 5 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $7,444 | 11 | $0 (2021) |
| Kala Pharmaceuticals, Inc. | $6,392 | 2 | $0 (2019) |
| AbbVie Inc. | $4,095 | 4 | $0 (2021) |
| Zambon USA Ltd. | $4,000 | 1 | $0 (2023) |
| Paratek Pharmaceuticals, Inc. | $3,979 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58,088 | 36 | VERTEX PHARMACEUTICALS INCORPORATED ($28,779) |
| 2023 | $73,165 | 41 | Insmed, Inc. ($46,361) |
| 2022 | $33,662 | 27 | Vertex Pharmaceuticals Incorporated ($23,956) |
| 2021 | $44,607 | 19 | Vertex Pharmaceuticals Incorporated ($30,973) |
| 2020 | $43,574 | 39 | Insmed, Inc. ($15,331) |
| 2019 | $93,013 | 75 | VERTEX PHARMACEUTICALS INCORPORATED ($58,483) |
| 2018 | $15,136 | 20 | Vertex Pharmaceuticals Incorporated ($9,436) |
| 2017 | $41,957 | 24 | VERTEX PHARMACEUTICALS INCORPORATED ($20,986) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $1,455.00 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,689.30 | General |
| 11/14/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $11,815.00 | General |
| 11/09/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $69.41 | General |
| Category: Respiratory | ||||||
| 11/08/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $63.15 | General |
| Category: Respiratory | ||||||
| 10/13/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $1,234.94 | General |
| 10/12/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $34.31 | General |
| 10/12/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $13.00 | General |
| 10/11/2024 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $14,440.00 | General |
| 10/11/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $67.96 | General |
| 10/11/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $32.16 | General |
| 10/11/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $14.70 | General |
| 10/10/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $211.59 | General |
| 10/09/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $7,541.69 | General |
| 09/24/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $56.50 | General |
| 09/22/2024 | Insmed, Inc. | — | Travel and Lodging | In-kind items and services | $396.10 | General |
| 09/22/2024 | Insmed, Inc. | — | Travel and Lodging | In-kind items and services | $318.88 | General |
| 09/21/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 09/21/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 09/21/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 09/21/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $22.00 | General |
| 09/20/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 09/20/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 09/20/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 09/13/2024 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $2,910.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 224 | 265 | $90,804 | $23,403 |
| 2022 | 3 | 196 | 235 | $76,794 | $20,555 |
| 2021 | 4 | 231 | 284 | $84,963 | $24,153 |
| 2020 | 6 | 289 | 346 | $72,764 | $17,402 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 101 | 119 | $46,291 | $11,926 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 94 | 117 | $30,303 | $7,928 | 26.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 29 | 29 | $14,210 | $3,550 | 25.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 75 | 91 | $34,419 | $9,398 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 90 | 113 | $27,635 | $6,916 | 25.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 31 | 31 | $14,740 | $4,240 | 28.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 125 | 173 | $36,627 | $11,650 | 31.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 58 | 63 | $20,214 | $6,864 | 34.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 36 | 36 | $15,318 | $4,375 | 28.6% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2021 | 12 | 12 | $12,804 | $1,264 | 9.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 104 | 148 | $28,718 | $8,193 | 28.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 58 | 71 | $20,755 | $5,530 | 26.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 20 | 20 | $8,248 | $2,359 | 28.6% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2020 | 13 | 13 | $6,721 | $697.57 | 10.4% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2020 | 46 | 46 | $5,106 | $297.42 | 5.8% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2020 | 32 | 32 | $1,440 | $220.10 | 15.3% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 16 | 16 | $1,776 | $104.48 | 5.9% |
About Dr. Patrick Flume, MD
Dr. Patrick Flume, MD is a Pulmonary Disease healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013011899.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Flume, MD has received a total of $403,202 in payments from pharmaceutical and medical device companies, with $58,088 received in 2024. These payments were reported across 281 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($206,668).
As a Medicare-enrolled provider, Flume has provided services to 940 Medicare beneficiaries, totaling 1,130 services with total Medicare billing of $85,512. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Charleston, SC
- Active Since 09/12/2006
- Last Updated 08/03/2011
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1013011899
Products in Payments
- Arikayce (Drug) $22,664
- KALYDECO (Drug) $20,850
- Cipro (Drug) $19,666
- The Vest System 205 Acute Care (Device) $10,714
- OFEV (Drug) $7,275
- NUZYRA (Drug) $3,979
- TRIKAFTA (Drug) $2,888
- The Vest System Model 105 Home Care (Device) $2,730
- ZERBAXA (Drug) $1,700
- QUINSAIR (Drug) $1,652
- KITABIS PAK (Drug) $1,628
- ORKAMBI (Drug) $1,601
- TOBI PODHALER (Drug) $920.00
- 4 (Drug) $600.00
- AFREZZA (Drug) $273.29
- XOLAIR (Biological) $70.42
- BETHKIS (Drug) $46.66
- The Monarch Airway Clearance System (Device) $30.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Charleston
Dr. Gerard Silvestri, Md, MD
Pulmonary Disease — Payments: $310,648
Charlton Strange, Md, MD
Pulmonary Disease — Payments: $232,160
Timothy Whelan, Md, MD
Pulmonary Disease — Payments: $79,200
Dr. John Huggins, Md, MD
Pulmonary Disease — Payments: $77,712
Marc Judson, Md, MD
Pulmonary Disease — Payments: $34,008
Dr. Luca Paoletti, Md, MD
Pulmonary Disease — Payments: $8,013